Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.06
+0.18 (2.35%)
At close: Jun 12, 2026, 4:00 PM EDT
8.21
+0.16 (1.92%)
After-hours: Jun 12, 2026, 6:54 PM EDT
Kyverna Therapeutics Employees
Kyverna Therapeutics had 130 employees as of December 31, 2025. The number of employees increased by 18 or 16.07% compared to the previous year.
Employees
130
Change (1Y)
18
Growth (1Y)
16.07%
Revenue / Employee
n/a
Profits / Employee
-$1,203,077
Market Cap
487.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 130 | 18 | 16.07% |
| Dec 31, 2024 | 112 | 16 | 16.67% |
| Dec 31, 2023 | 96 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Arvinas | 246 |
| ProKidney | 231 |
| 4D Molecular Therapeutics | 196 |
| Cabaletta Bio | 158 |
| Prime Medicine | 146 |
| Sutro Biopharma | 133 |
| Neurogene | 131 |
KYTX News
- 9 days ago - Kyverna Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 9 days ago - Kyverna Therapeutics presents updated COMPARE trial data at EULAR - TheFly
- 9 days ago - Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis - GlobeNewsWire
- 9 days ago - Kyverna Therapeutics Slides: Corporate presentation - Filings
- 16 days ago - Kyverna Therapeutics Transcript: AGM 2026 - Transcripts
- 24 days ago - Kyverna Therapeutics Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 25 days ago - Kyverna Therapeutics CFO Marc Grasso to step down, Greg Martini to succeed - TheFly
- 25 days ago - Kyverna Therapeutics Names Greg Martini as Chief Financial Officer - GlobeNewsWire